tranexamic acid has been researched along with Substance Withdrawal Syndrome in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nemoto, W | 1 |
| Sato, T | 1 |
| Nakagawasai, O | 1 |
| Yaoita, F | 1 |
| Silberring, J | 1 |
| Tadano, T | 1 |
| Tan-No, K | 1 |
1 other study available for tranexamic acid and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
Topics: Animals; Blotting, Western; Fibrinolysin; Injections, Intraventricular; Male; Mice; Morphine Depende | 2013 |